Anti-Aging Drugs Global Market Report 2024

The anti-aging drugs market has grown strongly in recent years. It will grow from $53.76 billion in 2023 to $57.85 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth observed in the historical period can be attributed to several factors, including the increase in chronic diseases associated with aging, a growing awareness of aging-related health issues, regulatory support for aging research, and a consumer focus on wellness and longevity. These factors collectively contributed to the development and adoption of anti-aging drugs during this period.

The anti-aging drugs market is expected to see strong growth in the next few years. It will grow to $77.85 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The anticipated growth in the forecast period can be attributed to several factors, including the adoption of precision medicine approaches, the emergence of senolytic drugs, increased collaboration and partnerships in research, establishment of regulatory pathways for aging therapeutics, and a growing consumer adoption of anti-aging interventions. Noteworthy trends expected in the forecast period include the development of targeted therapies and personalized medicine, the use of senolytic drugs to address cellular senescence, advancements in gene therapy and CRISPR technologies, a focus on mitochondrial health, and the modulation of the microbiome for longevity.

The growth of the anti-aging drugs market is anticipated to be fueled by the increasing aging population. This demographic shift highlights a rising proportion of individuals aged 60 years or older compared to other age cohorts within societies. This shift is a consequence of advancements in healthcare, resulting in extended lifespans, declining fertility rates, and transformations in social and economic structures. Anti-aging medications are aimed at extending the healthy lifespan of individuals who display youthful characteristics. For instance, according to the World Health Organization in October 2022, projections indicate that by 2030, one in every six individuals globally will be over 60 years old, marking an increase from 1 billion to 1.4 billion elderly individuals by 2020. Additionally, as per the Eurostat database, individuals aged 65 and above constituted 21.1% of the population, witnessing a 0.3% rise from the previous year and a 3.1% increase from a decade earlier. Hence, the surge in the aging population significantly propels the growth of the anti-aging drugs market.

The expansion of the anti-aging drugs market is expected to be driven by an increase in people's disposable income. This rise in disposable income typically correlates with economic improvements, leading to elevated wages, salaries, and heightened healthcare expenditures. Disposable income plays a pivotal role in influencing the usage of anti-aging drugs, as individuals with higher income levels often possess better accessibility and affordability for these treatments. This accessibility contributes to increased utilization, aiming to preserve a youthful appearance and tackle age-related concerns. For instance, data from the Bureau of Economic Analysis in August 2023 revealed a $7.3 billion rise (less than 0.1%) in disposable personal income and a $144.6 billion increase (0.8%) in personal consumption expenditures (PCE). Thus, the upsurge in people's disposable income significantly drives the growth of the anti-aging drugs market.

Embracing product innovation stands as a significant trend gaining traction within the anti-aging drugs market. Companies within this sector are actively integrating innovative products to fortify their market presence. For example, in April 2023, SkinCeuticals, a US-based leader in advanced skincare, unveiled the corrective cream A.G.E Interrupter Advanced. This product amplifies collagen matrix integrity, featuring a formulation infused with wild fruit flavonoids, glycyrrhetinic acid, and concentrated proxy lane (20% more than the original A.G.E Interrupter). A.G.E. Interrupter Advanced sets itself apart from standard anti-aging products by addressing all stages of the glycation process, rectifying existing signs of aging, and safeguarding against new and recurring damage induced by A.G.E. formation.

Leading companies in the anti-aging drug market are channeling efforts towards the development of cutting-edge skincare solutions aimed at combatting age-related conditions, promoting longevity, and enhancing overall health and well-being. Advanced skincare solutions for anti-aging encompass a spectrum of innovative products and treatments meticulously designed to target and diminish aging signs. These solutions elevate skin health and appearance through the utilization of state-of-the-art technologies and formulations. For instance, in August 2022, NutriGlow Cosmetics Pvt. Ltd., an India-based beauty product provider, introduced a limited-edition line of anti-aging skincare products on their platform. This range includes items such as NutriGlow Advanced Organics Anti Pigmentation Serum, Anti Pigmentation Night Cream, Age Repair Tightening Serum, Age Repair Tightening Day Cream, Vitamin C Skin Lightening Serum, and Vitamin C Skin Lightening Night Cream. These dermatologically-tested anti-aging products are infused with Vitamin C and Hyaluronic Acid, addressing various skin concerns such as dark spots, fine lines, hyperpigmentation, discoloration, and uneven skin tone for consumers.

In July 2021, AbbVie Inc., a US-based pharmaceutical company specializing in the discovery and delivery of innovative medicines, successfully acquired Allergan plc for a total of $63 billion. This strategic acquisition is anticipated to bolster AbbVie's position as a well-diversified leader in crucial therapeutic categories. Allergan plc, also based in the United States, is a pharmaceutical company engaged in the manufacturing of medical aesthetics drugs and medical devices, which includes products related to anti-aging skincare.

Major companies operating in the anti-aging drugs market report are L'Oréal S.A., Galderma S.A., Merz Pharma GmbH & Co. KGaA, Sanofi S.A., Elysium Health Inc., Estée Lauder Companies Inc., AbbVie Inc., La Roche-Posay, Nu Skin Enterprises Inc., Dermafix Biotech Private Limited, The Procter & Gamble Company, Johnson & Johnson Services Inc., Sun Pharmaceutical Industries Ltd., BioTime Inc., PT. Daewoong Pharmaceutical Co. Ltd., Allergan plc, Daewoong Pharmaceutical Co. Ltd., MMJ PhytoTech Limited, Revitacare, SciVision Biotech, Canbex Therapeutics Ltd., Lumenis Ltd., Cynosure Inc., Age Sciences Inc., ALMA LASERS Ltd., Bausch Health Companies Inc., Hansen Supplements, Ponce De Leon Health Inc. , Youth & Earth, Vitality Pro.

North America was the largest region in the anti-aging drugs market in 2023. The regions covered in the anti-aging drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the anti-aging drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary types of anti-aging drugs include serums, creams, gels, and other formulations. Serums are clear, yellowish liquids that remain after blood clotting and removal of blood cells. These drugs fall into various classes, including hormonal therapy, antioxidants, enzymes, stem cells, and others, available in forms such as injectables, oral medications, and topical applications. Various ingredients such as retinoid, hyaluronic acid, alpha hydroxy acid, among others, are applied to the skin and hair, targeting skeletal and muscle health, age-related disorders, and other aspects of the aging process.

The anti-aging drugs market research report provides anti-aging drugs market statistics, including anti-aging drugs industry global market size, regional shares, competitors with a anti-aging drugs market share, detailed anti-aging drugs market segments, market trends and opportunities, and any further data you may need to thrive in the anti-aging drugs industry. This anti-aging drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The anti-aging drugs market consists of sales of dermal fillers, botulinum toxin, anti-wrinkle products, and anti-stretch mark products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.